ophthalmology

Nanoscope Therapeutics Names VP of Global Research and Development

by | Oct 27, 2023

Najam Sharif, Ph.D., DSc, has been appointed as vice president of global research and development by Dallas-based Nanoscope Therapeutics Inc., a clinical-stage biotechnology company developing gene therapies for inherited retinal diseases.

Sharif is a veteran in drug/device discovery and development, the company said.

“We are delighted to welcome Naj to the Nanoscope team,” Sulagna Bhattacharya, co-founder and CEO of Nanoscope, said in a statement....

MORE
Nanoscope Therapeutics Strengthens Clinical, Regulatory Expertise with Appointment of Chief Medical Officer
by | Sep 22, 2023
Samuel Barone, M.D., is a former Federal Drug Administration official and leader in the pharmaceutical space.
MORE
Ho Din Award: Southwestern Medical Foundation Recognizes UTSW Medical Student With Its Highest Honor
by | May 12, 2023
Plano native Whitney Leigh Stuard is the winner of the 2023 Ho Din Award. As a co-founder of a student interest group focused on disabilities and a non-profit organization providing support to mothers, Stuard's contributions extend beyond her medical prowess. She also authored and received a TMA Foundation Grant for a STEM project that impacted more than 4,000 students.
MORE
Fort Worth Ophthalmic Biotech Eyevance Exits to Japanese Firm for $225M
by | Sep 17, 2020
Eyevance Pharmaceuticals, which develops and commercializes ophthalmic products, has been purchased for $225 million by Santen, a Japanese leader in ophthalmology. Eyevance will join Santen's U.S. organization.
MORE

Discovery: Work on Crystals Pays off for UTD Grad Student; UTSW Targets Rare Genetic Diseases in Children

by | May 10, 2019
You’ll also find out why the Association for Research in Vision and Ophthalmology has honored a professor at the UNT Health Science Center in Fort Worth in this roundup of research and development activity in North Texas.
MORE